Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist

Pinna, A; Costa, G; Serra, M; Contu, L; Morelli, M

Pinna, A (corresponding author), Cittadella Univ Monserrato, Neurosci Inst Cagliari, Natl Res Council Italy CNR, Dept Biomed Sci, I-09042 Monserrato, CA, Italy.

NEUROPHARMACOLOGY, 2021; 196 ():

Abstract

Several lines of evidence have strongly implicated neuroinflammation in Parkinson's disease (PD) progression and L-dopa-induced dyskinesia. The presen......

Full Text Link